Concepedia

Sarah R. Friedrich

SR

Statistics

Publications

3

Citations

98

H-Index

3

Active since

2001

Affiliations

University of Pennsylvania(Current)

Sarah R. Friedrich is an author at University of Pennsylvania specializing in pharmacology, pharmacy, and drug discovery.

Publications per year

2001–2007

3

Publications

3

Design and Synthesis of Novel Scaffolds for Drug Discovery:  Hybrids of β-<scp>d</scp>-Glucose with 1,2,3,4-Tetrahydrobenzo[<i>e</i>][1,4]diazepin-5-one, the Corresponding 1-Oxazepine, and 2- and 4-Pyridyldiazepines

Leïla Abrous, John Hynes, Sarah R. Friedrich et al. · Organic Letters · 2001 · 54 citations

, , +17

Novel Chimeric Scaffolds to Extend the Exploration of Receptor Space:  Hybrid β-<scp>d</scp>-Glucose−Benzoheterodiazepine Structures for Broad Screening. Effect of Amide Alkylation on the Course of Cyclization Reactions

Leïla Abrous, Patrick A. Jokiel, Sarah R. Friedrich et al. · The Journal of Organic Chemistry · 2003 · 28 citations

, , +13

Capped diaminopropionamide–glycine dipeptides are inhibitors of CC chemokine receptor 2 (CCR2)

Percy H. Carter, Gregory D. Brown, Sarah R. Friedrich et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 16 citations · Full text

, , +14

1–3 of 3